| Date Filed | Type | Description |
| 01/26/2023 |
3
| Hetterly Chris (CFO) has filed a Form 3 on NANOMIX Corp |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/21/2022 |
4
| GRUENER GARRETT (10% Owner) has filed a Form 4 on NANOMIX Corp|
Txns:
| Converted 25,160,338 shares
@ $0
Bought 32 shares
@ $0.57, valued at
$18.2
Bought 2,968 shares
@ $0.4, valued at
$1.2k
Bought 1,500 shares
@ $0.36, valued at
$540
Bought 11,500 shares
@ $0.4, valued at
$4.6k
Acquired options to buy
@ $0.0119, valued at
$0
Acquired 134,771,261 warrants
@ $0.0119, valued at
$1.6M
Bought options to buy
@ $0.0119, valued at
$0
Bought 37,348,235 warrants
@ $0.0119, valued at
$444.4k
|
|
| 09/21/2022 |
3
| GRUENER GARRETT (10% Owner) has filed a Form 3 on NANOMIX Corp |
| 06/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/07/2018 |
3
| Upham Loraine (COO) has filed a Form 3 on Boston Therapeutics, Inc. |
| 05/10/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/08/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $0.12, valued at
$600
Bought 1,000 shares
@ $0.1476, valued at
$147.6 |
|
| 03/20/2015 |
4
| ESBER HENRY JEMIL (Director) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 9,000 shares
@ $0.2, valued at
$1.8k
Granted 6,000 options
@ $0.37, valued at
$2.2k
|
|
| 03/16/2015 |
4
| Hoberman Alan M (Director) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $0.22, valued at
$1.1k
|
|
| 03/11/2015 |
4
| SQUEGLIA ANTHONY DON (CFO) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.22, valued at
$2.2k
|
|
| 03/10/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 3,000 shares
@ $0.205, valued at
$615
Bought 3,000 shares
@ $0.21, valued at
$630
Bought 2,285 shares
@ $0.23, valued at
$525.6
Bought 465 shares
@ $0.24, valued at
$111.6
Bought 1,250 shares
@ $0.245, valued at
$306.3 |
|
| 02/19/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 250 shares
@ $0.58, valued at
$145 |
|
| 02/13/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 250 shares
@ $0.51, valued at
$127.5 |
|
| 02/04/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 200 shares
@ $0.478, valued at
$95.6
Bought 200 shares
@ $0.41, valued at
$82
Bought 200 shares
@ $0.41, valued at
$82 |
|
| 01/29/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 200 shares
@ $0.39, valued at
$78
Bought 200 shares
@ $0.42, valued at
$84
Bought 200 shares
@ $0.509, valued at
$101.8
Bought 200 shares
@ $0.4799, valued at
$96 |
|
| 01/27/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $0.4, valued at
$200 |
|
| 01/23/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 3,000 shares
@ $0.34, valued at
$1k
|
|
| 01/20/2015 |
4/A
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $0.5999, valued at
$300
Bought 100 shares
@ $0.5999, valued at
$60 |
|
| 01/16/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $0.5999, valued at
$300
Bought 500 shares
@ $0.5999, valued at
$300 |
|
| 01/12/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $0.6787, valued at
$339.4
Bought 1,000 shares
@ $0.5999, valued at
$599.9 |
|
| 01/08/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 200 shares
@ $0.5799, valued at
$116
Bought 500 shares
@ $0.6787, valued at
$339.4 |
|
| 01/07/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 100 shares
@ $0.5999, valued at
$60 |
|
| 01/05/2015 |
4
| PLATT DAVID (CEO and Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $0.6488, valued at
$648.8
Bought 100 shares
@ $0.64, valued at
$64 |
|
| 12/31/2014 |
4
| PLATT DAVID (CEO, Treasurer, Chairman) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $0.6, valued at
$600
Bought 1,000 shares
@ $0.6699, valued at
$669.9
Bought 1,000 shares
@ $0.6487, valued at
$648.7 |
|
| 04/30/2014 |
4
| Cheng Conroy Chi-Heng (Director) has filed a Form 4 on Boston Therapeutics, Inc.|
Txns:
| Granted 24,000 options
@ $1.21, valued at
$29k
|
|
|